journal
https://read.qxmd.com/read/38589651/a-missense-mutation-in-human-insc-causes-peripheral-neuropathy
#1
JOURNAL ARTICLE
Jui-Yu Yeh, Hua-Chuan Chao, Cheng-Li Hong, Yu-Chien Hung, Fei-Yang Tzou, Cheng-Tsung Hsiao, Jeng-Lin Li, Wen-Jie Chen, Cheng-Ta Chou, Yu-Shuen Tsai, Yi-Chu Liao, Yu-Chun Lin, Suewei Lin, Shu-Yi Huang, Marina Kennerson, Yi-Chung Lee, Chih-Chiang Chan
PAR3/INSC/LGN form an evolutionarily conserved complex required for asymmetric cell division in the developing brain, but its post-developmental function and disease relevance in the peripheral nervous system (PNS) remains unknown. We mapped a new locus for axonal Charcot-Marie-Tooth disease (CMT2) and identified a missense mutation c.209 T > G (p.Met70Arg) in the INSC gene. Modeling the INSCM70R variant in Drosophila, we showed that it caused proprioceptive defects in adult flies, leading to gait defects resembling those in CMT2 patients...
April 8, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38589650/foxf1-promotes-tumor-vessel-normalization-and-prevents-lung-cancer-progression-through-fzd4
#2
JOURNAL ARTICLE
Fenghua Bian, Chinmayee Goda, Guolun Wang, Ying-Wei Lan, Zicheng Deng, Wen Gao, Anusha Acharya, Abid A Reza, Jose Gomez-Arroyo, Nawal Merjaneh, Xiaomeng Ren, Jermaine Goveia, Peter Carmeliet, Vladimir V Kalinichenko, Tanya V Kalin
Cancer cells re-program normal lung endothelial cells (EC) into tumor-associated endothelial cells (TEC) that form leaky vessels supporting carcinogenesis. Transcriptional regulators that control the reprogramming of EC into TEC are poorly understood. We identified Forkhead box F1 (FOXF1) as a critical regulator of EC-to-TEC transition. FOXF1 was highly expressed in normal lung vasculature but was decreased in TEC within non-small cell lung cancers (NSCLC). Low FOXF1 correlated with poor overall survival of NSCLC patients...
April 8, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38570712/genome-wide-crispr-screens-identify-pkmyt1-as-a-therapeutic-target-in-pancreatic-ductal-adenocarcinoma
#3
JOURNAL ARTICLE
Simin Wang, Yangjie Xiong, Yuxiang Luo, Yanying Shen, Fengrui Zhang, Haoqi Lan, Yuzhi Pang, Xiaofang Wang, Xiaoqi Li, Xufen Zheng, Xiaojing Lu, Xiaoxiao Liu, Yumei Cheng, Tanwen Wu, Yue Dong, Yuan Lu, Jiujie Cui, Xiaona Jia, Sheng Yang, Liwei Wang, Yuexiang Wang
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with an overall 5-year survival rate of <12% due to the lack of effective treatments. Novel treatment strategies are urgently needed. Here, PKMYT1 is identified through genome-wide CRISPR screens as a non-mutant, genetic vulnerability of PDAC. Higher PKMYT1 expression levels indicate poor prognosis in PDAC patients. PKMYT1 ablation inhibits tumor growth and proliferation in vitro and in vivo by regulating cell cycle progression and inducing apoptosis...
April 3, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38565807/amylopectinosis-of-the-fatal-epilepsy-lafora-disease-resists-autophagic-glycogen-catabolism
#4
LETTER
Jun Wu, Or Kakhlon, Miguel Weil, Alexander Lossos, Berge A Minassian
No abstract text is available yet for this article.
April 2, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38565806/immunopet-imaging-of-trop2-in-patients-with-solid-tumours
#5
JOURNAL ARTICLE
Wei Huang, You Zhang, Min Cao, Yanfei Wu, Feng Jiao, Zhaohui Chu, Xinyuan Zhou, Lianghua Li, Dongsheng Xu, Xinbing Pan, Yihui Guan, Gang Huang, Jianjun Liu, Fang Xie, Weijun Wei
Accurately predicting and selecting patients who can benefit from targeted or immunotherapy is crucial for precision therapy. Trophoblast cell surface antigen 2 (Trop2) has been extensively investigated as a pan-cancer biomarker expressed in various tumours and plays a crucial role in tumorigenesis through multiple signalling pathways. Our laboratory successfully developed two 68 Ga-labelled nanobody tracers that can rapidly and specifically target Trop2. Of the two tracers, [68 Ga]Ga-NOTA-T4, demonstrated excellent pharmacokinetics in preclinical mouse models and a beagle dog...
April 2, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38565805/oxidized-glutathione-reverts-carbapenem-resistance-in-bla-ndm-1-carrying-escherichia-coli
#6
JOURNAL ARTICLE
Dongyang Ye, Xiaowei Li, Liang Zhao, Saiwa Liu, Xixi Jia, Zhinan Wang, Jingjing Du, Lirui Ge, Jianzhong Shen, Xi Xia
The emergence of drug-resistant Enterobacteriaceae carrying plasmid-mediated β-lactamase genes has become a significant threat to public health. Organisms in the Enterobacteriaceae family containing New Delhi metallo-β-lactamase‑1 (NDM-1) and its variants, which are capable of hydrolyzing nearly all β-lactam antibacterial agents, including carbapenems, are referred to as superbugs and distributed worldwide. Despite efforts over the past decade, the discovery of an NDM-1 inhibitor that can reach the clinic remains a challenge...
April 2, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38528140/gene-therapy-for-deafness-are-we-there-now
#7
JOURNAL ARTICLE
Tobias Moser, Han Chen, Kathrin Kusch, Rüdiger Behr, Barbara Vona
No abstract text is available yet for this article.
March 25, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38514794/the-cb-1-receptor-interacts-with-cereblon-and-drives-cereblon-deficiency-associated-memory-shortfalls
#8
JOURNAL ARTICLE
Carlos Costas-Insua, Alba Hermoso-López, Estefanía Moreno, Carlos Montero-Fernández, Alicia Álvaro-Blázquez, Irene B Maroto, Andrea Sánchez-Ruiz, Rebeca Diez-Alarcia, Cristina Blázquez, Paula Morales, Enric I Canela, Vicent Casadó, Leyre Urigüen, Gertrudis Perea, Luigi Bellocchio, Ignacio Rodríguez-Crespo, Manuel Guzmán
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function...
March 21, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38514793/early-induction-of-cytokine-release-syndrome-by-rapidly-generated-car-t-cells-in-preclinical-models
#9
JOURNAL ARTICLE
Arezoo Jamali, Naphang Ho, Angela Braun, Elham Adabi, Frederic B Thalheimer, Christian J Buchholz
Cytokine release syndrome (CRS) is a significant side-effect of conventional chimeric antigen receptor (CAR) T-cell therapy. To facilitate patient accessibility, short-term (st) CAR T cells, which are administered to patients only 24 h after vector exposure, are in focus of current investigations. Their impact on the incidence and severity of CRS has been poorly explored. Here, we evaluated CD19-specific stCAR T cells in preclinical models. In co-culture with tumor cells and monocytes, stCAR T cells exhibited anti-tumoral activity and potent release of CRS-related cytokines (IL-6, IFN-γ, TNF-α, GM-CSF, IL-2, IL-10)...
March 21, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38514792/a-new-malaria-vaccination-tool-based-on-replication-competent-plasmodium-falciparum-parasites
#10
JOURNAL ARTICLE
Diana Moita, Miguel Prudêncio
No abstract text is available yet for this article.
March 21, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38514791/a-replication-competent-plasmodium-falciparum-parasite-completely-attenuated-by-dual-gene-deletion
#11
JOURNAL ARTICLE
Debashree Goswami, Hardik Patel, William Betz, Janna Armstrong, Nelly Camargo, Asha Patil, Sumana Chakravarty, Sean C Murphy, B Kim Lee Sim, Ashley M Vaughan, Stephen L Hoffman, Stefan Hi Kappe
Vaccination with infectious Plasmodium falciparum (Pf) sporozoites (SPZ) administered with antimalarial drugs (PfSPZ-CVac), confers superior sterilizing protection against infection when compared to vaccination with replication-deficient, radiation-attenuated PfSPZ. However, the requirement for drug administration constitutes a major limitation for PfSPZ-CVac. To obviate this limitation, we generated late liver stage-arresting replication competent (LARC) parasites by deletion of the Mei2 and LINUP genes (mei2- /linup- or LARC2)...
March 21, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38504136/fine-tuning-fam161a-gene-augmentation-therapy-to-restore-retinal-function
#12
JOURNAL ARTICLE
Yvan Arsenijevic, Ning Chang, Olivier Mercey, Younes El Fersioui, Hanna Koskiniemi-Kuendig, Caroline Joubert, Alexis-Pierre Bemelmans, Carlo Rivolta, Eyal Banin, Dror Sharon, Paul Guichard, Virginie Hamel, Corinne Kostic
For 15 years, gene therapy has been viewed as a beacon of hope for inherited retinal diseases. Many preclinical investigations have centered around vectors with maximal gene expression capabilities, yet despite efficient gene transfer, minimal physiological improvements have been observed in various ciliopathies. Retinitis pigmentosa-type 28 (RP28) is the consequence of bi-allelic null mutations in the FAM161A, an essential protein for the structure of the photoreceptor connecting cilium (CC). In its absence, cilia become disorganized, leading to outer segment collapses and vision impairment...
March 19, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38480933/treatment-with-brichos-domain-helps-to-clarify-issues-with-alzheimer-mouse-models
#13
LETTER
Jan Johansson
No abstract text is available yet for this article.
March 13, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38480932/basal-epithelial-subpopulations-underlie-and-predict-chemotherapy-resistance-in-triple-negative-breast-cancer
#14
JOURNAL ARTICLE
Mohammed Inayatullah, Arun Mahesh, Arran K Turnbull, J Michael Dixon, Rachael Natrajan, Vijay K Tiwari
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, characterized by extensive intratumoral heterogeneity, high metastasis, and chemoresistance, leading to poor clinical outcomes. Despite progress, the mechanistic basis of these aggressive behaviors remains poorly understood. Using single-cell and spatial transcriptome analysis, here we discovered basal epithelial subpopulations located within the stroma that exhibit chemoresistance characteristics. The subpopulations are defined by distinct signature genes that show a frequent gain in copy number and exhibit an activated epithelial-to-mesenchymal transition program...
March 13, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38480931/reply-to-johansson-treatment-with-brichos-domain-helps-to-clarify-issues-with-alzheimer-mouse-models
#15
LETTER
Luciano D'Adamio
No abstract text is available yet for this article.
March 13, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38472366/organotypic-culture-of-human-brain-explants-as-a-preclinical-model-for-ai-driven-antiviral-studies
#16
JOURNAL ARTICLE
Emma Partiot, Barbara Gorda, Willy Lutz, Solène Lebrun, Pierre Khalfi, Stéphan Mora, Benoit Charlot, Karim Majzoub, Solange Desagher, Gowrishankar Ganesh, Sophie Colomb, Raphael Gaudin
Viral neuroinfections represent a major health burden for which the development of antivirals is needed. Antiviral compounds that target the consequences of a brain infection (symptomatic treatment) rather than the cause (direct-acting antivirals) constitute a promising mitigation strategy that requires to be investigated in relevant models. However, physiological surrogates mimicking an adult human cortex are lacking, limiting our understanding of the mechanisms associated with viro-induced neurological disorders...
March 12, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38467841/the-communicatome-of-pregnancy-spotlight-on-cellular-and-extravesicular-chimerism
#17
REVIEW
Isabel Graf, Christopher Urbschat, Petra C Arck
Communication via biological mediators between mother and fetus are key to reproductive success and offspring's future health. The repertoire of mediators coding signals between mother and fetus is broad and includes soluble factors, membrane-bound particles and immune as well as non-immune cells. Based on the emergence of technological advancements over the last years, considerable progress has been made toward deciphering the "communicatome" between fetus and mother during pregnancy and even after birth. In this context, pregnancy-associated chimerism has sparked the attention among immunologists, since chimeric cells-although low in number-are maintained in the allogeneic host (mother or fetus) for years after birth...
March 11, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38467840/cytosolic-dna-sensors-in-neurodegenerative-diseases-from-physiological-defenders-to-pathological-culprits
#18
REVIEW
Jiatian Xie, Jinping Cheng, Ho Ko, Yamei Tang
Cytosolic DNA sensors are a group of pattern recognition receptors (PRRs) that vary in structures, molecular mechanisms, and origins but share a common function to detect intracellular microbial DNA and trigger the innate immune response like type 1 interferon production and autophagy. Cytosolic DNA sensors have been proven as indispensable defenders against the invasion of many pathogens; however, growing evidence shows that self-DNA misplacement to cytoplasm also frequently occurs in non-infectious circumstances...
March 11, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38467839/lipidomics-reveals-new-lipid-based-lung-adenocarcinoma-early-diagnosis-model
#19
JOURNAL ARTICLE
Ting Sun, Junge Chen, Fan Yang, Gang Zhang, Jiahao Chen, Xun Wang, Jing Zhang
Lung adenocarcinoma (LUAD) continues to pose a significant mortality risk with a lack of dependable biomarkers for early noninvasive cancer detection. Here, we find that aberrant lipid metabolism is significantly enriched in lung cancer cells. Further, we identified four signature lipids highly associated with LUAD and developed a lipid signature-based scoring model (LSRscore). Evaluation of LSRscore in a discovery cohort reveals a robust predictive capability for LUAD (AUC: 0.972), a result further validated in an independent cohort (AUC: 0...
March 11, 2024: EMBO Molecular Medicine
https://read.qxmd.com/read/38462666/antiviral-drugs-prolong-survival-in-murine-recessive-dystrophic-epidermolysis-bullosa
#20
JOURNAL ARTICLE
Grace Tartaglia, Ignacia Fuentes, Neil Patel, Abigail Varughese, Lauren E Israel, Pyung Hun Park, Michael H Alexander, Shiv Poojan, Qingqing Cao, Brenda Solomon, Zachary M Padron, Jonathan A Dyer, Jemima E Mellerio, John A McGrath, Francis Palisson, Julio Salas-Alanis, Lin Han, Andrew P South
Recessive dystrophic epidermolysis bullosa (RDEB) is a rare inherited skin disease characterized by defects in type VII collagen leading to a range of fibrotic pathologies resulting from skin fragility, aberrant wound healing, and altered dermal fibroblast physiology. Using a novel in vitro model of fibrosis based on endogenously produced extracellular matrix, we screened an FDA-approved compound library and identified antivirals as a class of drug not previously associated with anti-fibrotic action. Preclinical validation of our lead hit, daclatasvir, in a mouse model of RDEB demonstrated significant improvement in fibrosis as well as overall quality of life with increased survival, weight gain and activity, and a decrease in pruritus-induced hair loss...
March 10, 2024: EMBO Molecular Medicine
journal
journal
42177
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.